RA Capital Management’s Orchard Therapeutics plc American Depositary Shares ORTX Stock Holding History

RA Capital Management’s Portfolio ORTX Stock Details ORTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-304,089	Closed	-$1.78M	–	99
2022 Q2	$1.78M	Sell	304,089 -665,390	-69%	-$3.75M	0.05%	82
2022 Q1	$6.9M	Hold	969,479	–	–	0.15%	85
2021 Q4	$12.8M	Sell	969,479 -133,393	-12%	-$2.21M	0.23%	72
2021 Q3	$25.4M	Sell	1,102,872 -128,649	-10%	-$3.83M	0.35%	58
2021 Q2	$54.1M	Hold	1,231,521	–	–	0.87%	36
2021 Q1	$69.2M	Hold	1,231,521	–	–	1.04%	31
2020 Q4	$41.2M	Hold	1,231,521	–	–	0.58%	46
2020 Q3	$50.6M	Buy	1,231,521 +191,202	+18%	+$9.88M	0.93%	34
2020 Q2	$45.7M	Buy	1,040,319 +3,853	+0.4%	+$353K	0.89%	30
2020 Q1	$57M	Buy	1,036,466 +397,476	+62%	+$45.8M	1.8%	21
2019 Q4	$87.9M	Buy	638,990 +116,542	+22%	+$14.2M	2.66%	12
2019 Q3	$62.1M	Buy	522,448 +11,615	+2%	+$1.62M	3.7%	9
2019 Q2	$71.5M	Hold	510,833	–	–	3.84%	7
2019 Q1	$91.3M	Buy	510,833 +26,240	+5%	+$3.94M	3.94%	7
2018 Q4	$76.2M	Buy	+484,593	New	+$72.2M	4.44%	6

Other funds holding ORTX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

CHI Advisors New York $252M AUM 56.99% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

RA Capital Management's ORTX Position: Q3 2022 in Review

RA Capital Management sold out of Orchard Therapeutics plc American Depositary Shares (ORTX) in Q3 2022, closing a stake of 304,089 shares — an estimated $1.78M sold.

RA Capital Management first reported a position in ORTX in Q4 2018 and held it in 15 quarters. The position peaked at $91.3M in Q1 2019. 47 funds tracked by Wall St. Rank hold ORTX as of Q3 2022.

RA Capital Management reported no remaining Orchard Therapeutics plc American Depositary Shares position as of Q3 2022 after selling out during the quarter.
RA Capital Management sold 304,089 Orchard Therapeutics plc American Depositary Shares shares in Q3 2022, an estimated $1.78M.
RA Capital Management first reported a position in Orchard Therapeutics plc American Depositary Shares in Q4 2018 and held it in 15 quarters.
RA Capital Management's Orchard Therapeutics plc American Depositary Shares position peaked at $91.3M in Q1 2019.
47 funds tracked by Wall St. Rank held Orchard Therapeutics plc American Depositary Shares as of Q3 2022.

Based on RA Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.